Physician

Maxwell Stem, M.D.

According to 2025 Medicare claims, Maxwell Stem, M.D. (NPI: 1093033300) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is PENNSYLVANIA RETINA SPECIALISTS PC (NPI: 1568428126; TIN: 232152842) and primary practice location at 17011-1776.

Stem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 879 traditional Medicare patients, billed 36,612 HCPCS/CPT codes, and received $2,866,223 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 584 prescription claims across 184 beneficiaries totaling $194,255 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 7 records totaling $350. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $17,398 to $2,866,223. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $18,953 to $194,255. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2016 Medicare payment: $17,398 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $24,936 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,092,795 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,504,190 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,788,257 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,017,873 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,059,958 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,926,783 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,866,223 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201687154$17,398
2017172280$24,936
20189165,425$1,092,795
20191,60512,781$2,504,190
20201,14912,477$2,788,257
20211,06912,326$3,017,873
202295315,204$3,059,958
202396733,900$2,926,783
202487936,612$2,866,223

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$97K$194K2015 Drug cost: $18,953 (USD; Tot_Drug_Cst)2016 Drug cost: $35,250 (USD; Tot_Drug_Cst)2017 Drug cost: $16,461 (USD; Tot_Drug_Cst)2018 Drug cost: $22,284 (USD; Tot_Drug_Cst)2019 Drug cost: $35,304 (USD; Tot_Drug_Cst)2020 Drug cost: $99,437 (USD; Tot_Drug_Cst)2021 Drug cost: $86,944 (USD; Tot_Drug_Cst)2022 Drug cost: $122,039 (USD; Tot_Drug_Cst)2023 Drug cost: $180,916 (USD; Tot_Drug_Cst)2024 Drug cost: $194,255 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598179$18,953
2016164461$35,250
2017186440$16,461
2018174422$22,284
2019152456$35,304
2020169466$99,437
2021161541$86,944
2022161475$122,039
2023176517$180,916
2024184584$194,255

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2331,916$648
67028Injection of drug into eye4071,756$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more556987$65
92134Imaging of retina7132,146$29
92250Photography of the retina240256$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept521,472$123,436
VabysmoFaricimab-Svoa13364$29,317
DifluprednateDifluprednate331,006$3,535
Prednisolone AcetatePrednisolone Acetate572,940$2,763
Ketorolac TromethamineKetorolac Tromethamine632,282$1,882

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$350Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Maxwell Stem, M.D.?

Tedicare shows public-source Medicare data for Maxwell Stem, M.D. (NPI 1093033300), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maxwell Stem, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maxwell Stem, M.D.?

Maxwell Stem, M.D. is linked to PENNSYLVANIA RETINA SPECIALISTS PC (billing NPI 1568428126) in the available physician profile data.

Does Maxwell Stem, M.D. have Open Payments data?

Maxwell Stem, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.